In a potentially groundbreaking development in the ongoing fight against the coronavirus, researchers from the University of Texas at Austin have announced the discovery of an antibody that could offer protection against all known variants of COVID-19. This discovery emerges amid a rise in COVID-19 cases that has been observed this summer. The research team managed to isolate "a broadly neutralizing plasma antibody, called SC27, from a single patient," the university has shared.
The innovative effort has not only identified an antibody with far-reaching potential but paved the way for the advancement of current COVID-19 treatments. As Will Voss, a recent Ph.D. graduate in cell and molecular biology at UT's College of Natural Sciences, and co-leader of the study explains, one major aim of their research is to "work toward a universal vaccine that can generate antibodies and create an immune response with broad protection to a rapidly mutating virus", according to KXAN.
With Texas among the states experiencing the highest number of cases, the discovery could mark a significant milestone. The Texas Medical Association, taking into account factors such as wastewater testing and COVID-19 test reporting, has indicated Texas's prominence in this summer's statistical uptick. Dr. Amesh Adalja, an infectious disease physician for Johns Hopkins University, pointed out that "In the summer, people get hot. They go indoors where we know the virus transmits more efficiently. The vaccines that are currently available right now are not well-matched to the variants that are circulating," he mentioned last month.
The next stage for the researchers at UT Austin is to hopefully work to ensure the antibody can be utilized in large-scale manufacturing for future treatments. The eventual goal is to bolster the defenses of individuals against not just the current strains, but also any future variants of the SARS-CoV-2 virus. As reported by FOX 7 Austin, the team believes this antibody could play a crucial role in protecting people against an ever-evolving viral threat. The process of translating this discovery into tangible treatments, while complex, is a crucial next step in the ongoing efforts to safeguard public health.
